RIP shRNA Plasmid (h2) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images
Published Figures

RIP shRNA Plasmid (h2)

Be the first to write a review!

Citations:

Figures:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
RIP shRNA Plasmid (h2)

Product Specs
ItemRIP shRNA Plasmid (h2)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-44326-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namereceptor (TNFRSF)-interacting serine-threonine kinase 1, receptor interacting serine/threonine kinase 1
NCBI Gene AliasesIMD57, AIEFL, RIP-1, D330015H01Rik, Rinp, RIP, RIP1, Rip1

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) ΜicroRNA‑421 participates in vitiligo development through regulating human melanocyte survival by targeting receptor‑interacting serine/threonine kinase 1Molecular medicine reportsFebruary 1, 2020Sun X, Wang T, Huang B, Ruan G, Xu A.0.2 µM control-shRNA (cat no. sc-108060; Santa Cruz Biotechnology, Inc.), 0.2 µM RIPK1-shRNA (cat no. sc-44326-SH; Santa Cruz Biotechnology, Inc.), miR-421 inhibitor + control-shRNA, or miR-421 inhibitor + RIPK1-shRNA

(2) Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanismsCancer lettersJuly 10, 2013Wang D, Lu J, Tindall DJ.

(3) Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesisCancerDecember 1, 2012Kamarajan P, Alhazzazi TY, Danciu T, D'silva NJ, Verdin E, Kapila YL.

(4) Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progressionCancer researchDecember 15, 2009Wang D, Montgomery RB, Schmidt LJ, Mostaghel EA, Huang H, Nelson PS, Tindall DJ.

Be the First to Write a Review!